Manufacturers Life Insurance Company, The Allakos Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.02 - $3.23 $96,507 - $305,606	-94,615 Reduced 77.12%	28,074 $35,000
Q3 2023 Nov 15, 2023	BUY	$2.13 - $5.55 $370 - $965	174 Added 0.14%	122,689 $278,000
Q2 2023 Aug 11, 2023	BUY	$3.6 - $5.25 $94,669 - $138,059	26,297 Added 27.33%	122,515 $534,000
Q4 2022 Aug 11, 2023	BUY	$5.66 - $8.42 $202,135 - $300,703	35,713 Added 59.02%	96,218 $810,000
Q4 2022 Feb 13, 2023	BUY	$5.66 - $8.42 $202,135 - $300,703	35,713 Added 59.02%	96,218 $810,000
Q3 2022 Aug 11, 2023	BUY	$3.02 - $6.12 $45,300 - $91,800	15,000 Added 32.96%	60,505 $317,000
Q3 2022 Nov 03, 2022	BUY	$3.02 - $6.12 $45,300 - $91,800	15,000 Added 32.96%	60,505 $339,000
Q2 2022 Aug 11, 2023	SELL	$2.6 - $6.14 $37,648 - $88,907	-14,480 Reduced 24.14%	45,505 $142,000
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $37,648 - $88,907	-14,480 Reduced 24.14%	45,505 $151,000
Q1 2022 Aug 11, 2023	SELL	$5.08 - $9.81 $184,063 - $355,445	-36,233 Reduced 37.66%	59,985 $341,000
Q1 2022 May 20, 2022	BUY	$5.08 - $9.81 $212,150 - $409,685	41,762 Added 229.17%	59,985 $341,000
Q4 2021 Feb 16, 2022	SELL	$8.55 - $111.89 $632 - $8,279	-74 Reduced 0.4%	18,223 $180,000
Q3 2021 Nov 12, 2021	SELL	$76.53 - $110.43 $129,794 - $187,289	-1,696 Reduced 8.48%	18,297 $1.94 Million
Q2 2021 Aug 12, 2021	BUY	$85.37 - $114.1 $407,727 - $544,941	4,776 Added 31.39%	19,993 $1.71 Million
Q1 2021 May 03, 2021	SELL	$109.73 - $153.66 $94,477 - $132,301	-861 Reduced 5.36%	15,217 $1.75 Million
Q4 2020 Feb 12, 2021	BUY	$79.58 - $152.45 $120,802 - $231,419	1,518 Added 10.43%	16,078 $2.25 Million
Q3 2020 Nov 09, 2020	SELL	$66.43 - $90.99 $27,767 - $38,033	-418 Reduced 2.79%	14,560 $1.19 Million
Q2 2020 Aug 10, 2020	BUY	$44.04 - $80.69 $86,230 - $157,991	1,958 Added 15.04%	14,978 $1.09 Million
Q1 2020 May 15, 2020	BUY	$44.49 - $93.39 $30,965 - $64,999	696 Added 5.65%	13,020 $579,000
Q4 2019 Feb 14, 2020	SELL	$66.49 - $137.73 $8,311 - $17,216	-125 Reduced 1.0%	12,324 $1.18 Million
Q3 2019 Nov 12, 2019	BUY	$31.0 - $89.73 $33,170 - $96,011	1,070 Added 9.4%	12,449 $984,000
Q2 2019 Aug 14, 2019	BUY	$36.0 - $44.73 $201,672 - $250,577	5,602 Added 96.97%	11,379 $493,000
Q1 2019 May 13, 2019	BUY	$33.79 - $51.99 $195,204 - $300,346	5,777 New	5,777 $234,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$16.1 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$5.96 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$4.85 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$3.41 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$2.99 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $82.2M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account